Gilead Sciences Ordered to Pay $2.5 Billion in Damages to Merck & Co.

A federal jury in Delaware on Thursday ordered Gilead Sciences Inc. to pay $2.5 billion in damages to Merck& Co. for infringing its patents in developing hepatitis C drugs.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news